CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (32,010)	$ 9,030
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation	9,079	7,201
Deferred income taxes	(2,220)	573
Amortizatoin of Financing Costs	110	110
Employee Benefits and Share-based Compensation	4,936	4,135
Impairment of intangible assets	15,200	0
Impairment of goodwill	23,626	0
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount	2,002	0
Change in accrual for unrecognized tax benefits	62	319
Gain (Loss) on Sale of Equity Investments	(200)	0
Loss on sale of business	0	537
Changes in operating assets and liabilities, net of the effects of acquisitions:
Accounts receivable	4,297	7,244
Prepaid expense and other assets	(251)	66
Capitalized contract costs	954	1,602
Accounts payable and accrued expenses	(2,895)	(8,144)
Income taxes receivable/payable	(126)	923
Deferred revenue	(9,499)	(4,774)
Other, net	1,379	166
Net cash flows from operating activities	14,444	18,988
Cash flows from (used in) investing activities:
Payments for (Proceeds from) Businesses and Interest in Affiliates	0	2,683
Payments for (Proceeds from) Investments	200	0
Purchases of fixed assets	(12,536)	(10,345)
Net cash flows from (used in) investing activities	(12,336)	(7,662)
Cash flows from financing activities:
Payments on long-term debt	(9,444)	(25,000)
Proceeds from long-term debt	36,444	15,000
Payments under stock repurchase plan	(5,930)	(1,762)
Purchase of treasury stock related to vested restricted stock	(1,742)	(1,366)
Net cash flows used in financing activities	19,328	(13,128)
Effect of exchange rate changes	(12)	(216)
Net change in cash and cash equivalents for the period	21,424	(2,018)
Cash and cash equivalents, beginning of period	5,381	6,472
Cash and cash equivalents, end of period	$ 26,805	$ 4,454